首页 > 最新文献

Arkhiv patologii最新文献

英文 中文
[Prognosis of poorly cohesive gastric carcinoma depending on the depth of tumor invasion and the amount of signet ring cells in tumor]. 【低黏结性胃癌的预后与肿瘤浸润深度及印戒细胞数量有关】。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258706120
S N Nered, N A Kozlov, R O Torosyan, I S Stilidi

Current data of the prognosis of signet ring cell gastric carcinoma (SRC) are contradictory, and our knowledge of other subtypes of poorly cohesive carcinoma is poor.

Objective: To study the prognosis of poorly cohesive gastric carcinoma depending on the amount of the signet ring cells and depth of tumor invasion in comparison with other types of gastric cancer (GC) according to the classification of P. Lauren.

Material and methods: In 315 patients with GC after surgical treatment, pathological tissue samples were reviewed by using a semi-quantitative assessment of the proportion of diffuse and intestinal components of the tumor to clarify the type of GC according to the P. Lauren classification, as well as the proportion of signet ring cells.

Results: In pT1-T2 tumors, 5-year overall survival (5-OS) in patients with diffuse and intestinal types of gastric cancer has demonstated no differences. In cases of serous membrane invasion (pT4a-T4b), the 5-OS rates in patients with poorly cohesive gastric carcinoma worsens sharply compared to the intestinal type (28.6% versus 49.7%, p=0.006) and becomes comparable with 5-OS in mixed type of gastric cancer (15.2%, p=0.644). As the depth of invasion increases, the amount of signet-ring cells in poorly cohesive cancer decreases. The highest percentage of signet ring cells was found when the tumor was localized within the mucous and submucous layers (27.5% for pT1a, 43.0% for pT1b). For pT2, the proportion of signet ring cells was 12.0%, for pT3 - 11.2%, pT4 - 8.3%. This feature explains the high percentage of early cancer in patients with signet ring cell (SRC) GC. No significant differences in 5-OV was found with poorly cohesive carcinoma depending on the amount of signet ring cells (≥1%, ≥10%, ≥50%, ≥90%).

Conclusion: Invasion of the serous membrane of the stomach contributes to the rapid implementation of the tendency of poorly cohesive gastric carcinoma to peritoneal dissemination of the tumor. The proportion of signet ring cells in poorly cohesive gastric carcinoma does not affect to aggressive properties of the tumor.

目前关于印戒细胞胃癌(SRC)预后的资料是相互矛盾的,我们对其他低粘连癌亚型的认识也很差。目的:探讨低黏结性胃癌与其他类型胃癌(GC)相比,印戒细胞数量及肿瘤浸润深度对预后的影响。材料与方法:315例手术治疗后胃癌患者,采用半定量评估肿瘤弥漫性成分和肠性成分的比例,根据P. Lauren分类明确胃癌类型,以及印戒细胞的比例,回顾病理组织样本。结果:在pT1-T2肿瘤中,弥漫性胃癌和肠型胃癌患者的5年总生存率(5-OS)无显著差异。在浆膜浸润(pT4a-T4b)的情况下,低黏结性胃癌患者的5-OS率与肠型相比急剧恶化(28.6%对49.7%,p=0.006),与混合型胃癌患者的5-OS率相当(15.2%,p=0.644)。随着浸润深度的增加,黏结性差的癌细胞中印戒细胞的数量减少。当肿瘤局限于粘膜和粘膜下层时,印环细胞的比例最高(pT1a为27.5%,pT1b为43.0%)。pT2的印戒细胞比例为12.0%,pT3为11.2%,pT4为8.3%。这一特征解释了印戒细胞(SRC) GC患者早期癌症的高比例。印戒细胞数量的不同(≥1%,≥10%,≥50%,≥90%)在低黏结癌中5-OV无显著差异。结论:胃浆膜的侵犯有助于低黏结性胃癌向腹膜扩散的趋势迅速实现。黏结性差的胃癌中印戒细胞的比例不影响肿瘤的侵袭性。
{"title":"[Prognosis of poorly cohesive gastric carcinoma depending on the depth of tumor invasion and the amount of signet ring cells in tumor].","authors":"S N Nered, N A Kozlov, R O Torosyan, I S Stilidi","doi":"10.17116/patol20258706120","DOIUrl":"https://doi.org/10.17116/patol20258706120","url":null,"abstract":"<p><p>Current data of the prognosis of signet ring cell gastric carcinoma (SRC) are contradictory, and our knowledge of other subtypes of poorly cohesive carcinoma is poor.</p><p><strong>Objective: </strong>To study the prognosis of poorly cohesive gastric carcinoma depending on the amount of the signet ring cells and depth of tumor invasion in comparison with other types of gastric cancer (GC) according to the classification of P. Lauren.</p><p><strong>Material and methods: </strong>In 315 patients with GC after surgical treatment, pathological tissue samples were reviewed by using a semi-quantitative assessment of the proportion of diffuse and intestinal components of the tumor to clarify the type of GC according to the P. Lauren classification, as well as the proportion of signet ring cells.</p><p><strong>Results: </strong>In pT1-T2 tumors, 5-year overall survival (5-OS) in patients with diffuse and intestinal types of gastric cancer has demonstated no differences. In cases of serous membrane invasion (pT4a-T4b), the 5-OS rates in patients with poorly cohesive gastric carcinoma worsens sharply compared to the intestinal type (28.6% versus 49.7%, <i>p</i>=0.006) and becomes comparable with 5-OS in mixed type of gastric cancer (15.2%, <i>p</i>=0.644). As the depth of invasion increases, the amount of signet-ring cells in poorly cohesive cancer decreases. The highest percentage of signet ring cells was found when the tumor was localized within the mucous and submucous layers (27.5% for pT1a, 43.0% for pT1b). For pT2, the proportion of signet ring cells was 12.0%, for pT3 - 11.2%, pT4 - 8.3%. This feature explains the high percentage of early cancer in patients with signet ring cell (SRC) GC. No significant differences in 5-OV was found with poorly cohesive carcinoma depending on the amount of signet ring cells (≥1%, ≥10%, ≥50%, ≥90%).</p><p><strong>Conclusion: </strong>Invasion of the serous membrane of the stomach contributes to the rapid implementation of the tendency of poorly cohesive gastric carcinoma to peritoneal dissemination of the tumor. The proportion of signet ring cells in poorly cohesive gastric carcinoma does not affect to aggressive properties of the tumor.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 6","pages":"20-27"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Another sight at Gastric Cancer Molecular Classification: novel subtypes based on expression of CDX-2, E-cadherin, Epstein-Barr virus RNAs, MMR proteins]. [胃癌分子分类:基于CDX-2、E-cadherin、Epstein-Barr病毒rna、MMR蛋白表达的新亚型]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258703149
N V Danilova, Yu Yu Andreeva, V M Khomyakov, A V Chaika, D V Kalinin, E E Porubayeva, P G Malkov

Objective: This study explores the immunohistochemical and prognostic characteristics of gastric cancer (GC).

Material and methods: The research analyzed surgical samples from 310 GC patients who had not received chemotherapy or radiotherapy prior to surgery. Each sample was immunohistochemically stained for 23 markers (MSH2, MSH6, MLH1, PMS2, MUC2, CDX2, MUC5AC, CD10, E-cadherin, β-catenin, Claudin-1, Claudin-3, Claudin-4, CD44, p53, PD-L1 (SP142), PD-L1 (SP236), HER2, CD4, CD8, CD68, CD1a, LMP-1), and in situ hybridization for Epstein-Barr virus RNA (EBER) was also conducted.

Results: The analysis led to the development of a molecular classification of gastric cancer, comprising five molecular subtypes: MMR-deficient, EBER-positive, E-cadherin aberrant, CDX2-positive, and CDX2-negative. The CDX2-positive subtype occurs in 49.7% of GC cases; it includes papillary and mucinous GC with less depth of invasion, no lymph node involvement, and lower clinical stage and has a relatively favorable prognosis (median survival 47 months). The CDX2-negative subtype occurs in 16.1% of GC cases; it includes tumors of diffuse and intermediate type by P. Lauren, primarily located distally in the stomach, with a greater depth of invasion and a higher clinical stage. The CDX2-negative subtype is characterized by positive expression of MUC5AC and unfavorable prognosis (median survival 23 months).

Conclusion: A new five-tier molecular classification of gastric cancer has been developed. Two of the five subtypes have been identified and characterized for the first time. The identified subtypes have promising implications for the targeted therapy of gastric malignancies.

目的:探讨胃癌(GC)的免疫组化及预后特点。材料和方法:本研究分析了310例术前未接受化疗或放疗的胃癌患者的手术样本。对每个样品进行23种标记物(MSH2、MSH6、MLH1、PMS2、MUC2、CDX2、MUC5AC、CD10、E-cadherin、β-catenin、Claudin-1、Claudin-3、Claudin-4、CD44、p53、PD-L1 (SP142)、PD-L1 (SP236)、HER2、CD4、CD8、CD68、CD1a、LMP-1)的免疫组织化学染色,并对eb病毒RNA (EBER)进行原位杂交。结果:该分析导致胃癌分子分类的发展,包括五个分子亚型:mmr缺陷,eber阳性,E-cadherin异常,cdx2阳性和cdx2阴性。cdx2阳性亚型占GC病例的49.7%;它包括乳头状和粘液性胃癌,浸润深度较小,未累及淋巴结,临床分期较低,预后相对较好(中位生存期为47个月)。16.1%的GC病例为cdx2阴性亚型;P. Lauren包括弥漫性和中间型肿瘤,主要位于胃远端,浸润深度较大,临床分期较高。cdx2阴性亚型的特点是MUC5AC阳性表达,预后不良(中位生存期23个月)。结论:建立了一种新的胃癌五层分子分类方法。五种亚型中有两种已被首次鉴定和鉴定。确定的亚型对胃恶性肿瘤的靶向治疗具有重要意义。
{"title":"[Another sight at Gastric Cancer Molecular Classification: novel subtypes based on expression of CDX-2, E-cadherin, Epstein-Barr virus RNAs, MMR proteins].","authors":"N V Danilova, Yu Yu Andreeva, V M Khomyakov, A V Chaika, D V Kalinin, E E Porubayeva, P G Malkov","doi":"10.17116/patol20258703149","DOIUrl":"10.17116/patol20258703149","url":null,"abstract":"<p><strong>Objective: </strong>This study explores the immunohistochemical and prognostic characteristics of gastric cancer (GC).</p><p><strong>Material and methods: </strong>The research analyzed surgical samples from 310 GC patients who had not received chemotherapy or radiotherapy prior to surgery. Each sample was immunohistochemically stained for 23 markers (MSH2, MSH6, MLH1, PMS2, MUC2, CDX2, MUC5AC, CD10, E-cadherin, β-catenin, Claudin-1, Claudin-3, Claudin-4, CD44, p53, PD-L1 (SP142), PD-L1 (SP236), HER2, CD4, CD8, CD68, CD1a, LMP-1), and in situ hybridization for Epstein-Barr virus RNA (EBER) was also conducted.</p><p><strong>Results: </strong>The analysis led to the development of a molecular classification of gastric cancer, comprising five molecular subtypes: MMR-deficient, EBER-positive, E-cadherin aberrant, CDX2-positive, and CDX2-negative. The CDX2-positive subtype occurs in 49.7% of GC cases; it includes papillary and mucinous GC with less depth of invasion, no lymph node involvement, and lower clinical stage and has a relatively favorable prognosis (median survival 47 months). The CDX2-negative subtype occurs in 16.1% of GC cases; it includes tumors of diffuse and intermediate type by P. Lauren, primarily located distally in the stomach, with a greater depth of invasion and a higher clinical stage. The CDX2-negative subtype is characterized by positive expression of MUC5AC and unfavorable prognosis (median survival 23 months).</p><p><strong>Conclusion: </strong>A new five-tier molecular classification of gastric cancer has been developed. Two of the five subtypes have been identified and characterized for the first time. The identified subtypes have promising implications for the targeted therapy of gastric malignancies.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 3","pages":"49-61"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sarcoid reaction with focal interstitial fibrosis in a COVID-19 patient with persistence of Sars-Cov-2 virus nucleocapsid and adhesion proteins in sarcoid granulomas and lung tissue]. [结节样反应伴局灶性间质纤维化,结节样肉芽肿和肺组织中持续存在Sars-Cov-2病毒核衣壳和粘附蛋白]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258704154
E A Kogan, S A Demura, M A Afonina

A case report of pulmonary sarcoidosis with fibrosis after COVID-19 is presented. Morphologic and immunohistochemical analysis of lung biopsies for Sars-Cov2 nucleocapsid and adhesion proteins was performed. Virus proteins were detected in alveolar macrophages, second-order pneumocytes and bronchiolar epithelium, also in granuloma-associated macrophages, multinucleated Pirogov-Langhans cells, indicating Sars-Cov2 persistence. Meanwhile, release of pro-inflammatory cytokines by granuloma cells and interstitial macrophages resulted in tissue damage and pulmonary fibrosis.

报告1例新型冠状病毒感染后肺结节病合并纤维化。对肺活检进行Sars-Cov2核衣壳和粘附蛋白的形态学和免疫组织化学分析。在肺泡巨噬细胞、二级肺细胞和细支气管上皮以及肉芽肿相关巨噬细胞、多核Pirogov-Langhans细胞中检测到病毒蛋白,表明Sars-Cov2持续存在。同时,肉芽肿细胞和间质巨噬细胞释放促炎细胞因子导致组织损伤和肺纤维化。
{"title":"[Sarcoid reaction with focal interstitial fibrosis in a COVID-19 patient with persistence of Sars-Cov-2 virus nucleocapsid and adhesion proteins in sarcoid granulomas and lung tissue].","authors":"E A Kogan, S A Demura, M A Afonina","doi":"10.17116/patol20258704154","DOIUrl":"10.17116/patol20258704154","url":null,"abstract":"<p><p>A case report of pulmonary sarcoidosis with fibrosis after COVID-19 is presented. Morphologic and immunohistochemical analysis of lung biopsies for Sars-Cov2 nucleocapsid and adhesion proteins was performed. Virus proteins were detected in alveolar macrophages, second-order pneumocytes and bronchiolar epithelium, also in granuloma-associated macrophages, multinucleated Pirogov-Langhans cells, indicating Sars-Cov2 persistence. Meanwhile, release of pro-inflammatory cytokines by granuloma cells and interstitial macrophages resulted in tissue damage and pulmonary fibrosis.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 4","pages":"54-57"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144940519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Placenta increta into the scar in combination with high-grade squamous intraepithelial lesion of the cervix]. [胎盘植入瘢痕合并宫颈高级别鳞状上皮内病变]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258702164
L V Tsoy, M O Kutusheva, I V Barinova, N B Paramonova, Yu V Lerner, V A Varshavskiy, T A Demura

Placenta increta is a pathological condition characterized by an invasion of placental tissue into the myometrium. The placenta doesn't detach naturally after delivery and cannot be separated without pathological hemorrhage. Previous cesarean section represents the main risk factor for the occurrence of placenta accreta. Pregnancy-related tissue changes complicate the identification of co-existing diseases of the cervix and uterine body. This case report discusses the characteristics and diagnostic methods of placenta increta in combination with cervical high-grade intraepithelial neoplasia in a 35-year-old female patient.

胎盘增生性是一种以胎盘组织侵入子宫肌层为特征的病理状况。胎盘在分娩后不能自然脱落,无病理性出血不能分离。既往剖宫产是发生胎盘增生的主要危险因素。妊娠相关的组织变化使子宫颈和子宫体共存疾病的识别复杂化。本病例报告讨论了一名35岁女性患者妊娠胎盘合并宫颈高级别上皮内瘤变的特点和诊断方法。
{"title":"[Placenta increta into the scar in combination with high-grade squamous intraepithelial lesion of the cervix].","authors":"L V Tsoy, M O Kutusheva, I V Barinova, N B Paramonova, Yu V Lerner, V A Varshavskiy, T A Demura","doi":"10.17116/patol20258702164","DOIUrl":"https://doi.org/10.17116/patol20258702164","url":null,"abstract":"<p><p>Placenta increta is a pathological condition characterized by an invasion of placental tissue into the myometrium. The placenta doesn't detach naturally after delivery and cannot be separated without pathological hemorrhage. Previous cesarean section represents the main risk factor for the occurrence of placenta accreta. Pregnancy-related tissue changes complicate the identification of co-existing diseases of the cervix and uterine body. This case report discusses the characteristics and diagnostic methods of placenta increta in combination with cervical high-grade intraepithelial neoplasia in a 35-year-old female patient.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 2","pages":"64-68"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143963735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Extragenital endometriosis without a glandular component with damage to the diaphragm and pleura]. [子宫外子宫内膜异位症,无腺体成分,膈膜和胸膜受损]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258702159
Z D Shtanev, N B Paramonova, N V Kovyazina, E E Shchelokova

Endometriosis continues to be a significant problem for women of childbearing age, with between 6 and 10 percent of women suffering from this condition. Despite its high prevalence, the diagnosis of endometriosis can be difficult due to its different localization and morphological characteristics. This article presents a case of endometriosis affecting the diaphragm and pleura, without a glandular component. The immunohistochemical examination was instrumental in confirming the diagnosis.

子宫内膜异位症仍然是育龄妇女的一个重大问题,有6%到10%的妇女患有这种疾病。尽管发病率很高,但由于其不同的定位和形态特征,诊断子宫内膜异位症可能很困难。这篇文章提出了一个病例子宫内膜异位症影响隔膜和胸膜,没有腺体成分。免疫组化检查有助于确诊。
{"title":"[Extragenital endometriosis without a glandular component with damage to the diaphragm and pleura].","authors":"Z D Shtanev, N B Paramonova, N V Kovyazina, E E Shchelokova","doi":"10.17116/patol20258702159","DOIUrl":"https://doi.org/10.17116/patol20258702159","url":null,"abstract":"<p><p>Endometriosis continues to be a significant problem for women of childbearing age, with between 6 and 10 percent of women suffering from this condition. Despite its high prevalence, the diagnosis of endometriosis can be difficult due to its different localization and morphological characteristics. This article presents a case of endometriosis affecting the diaphragm and pleura, without a glandular component. The immunohistochemical examination was instrumental in confirming the diagnosis.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 2","pages":"59-63"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143966428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prognostic value of molecular markers IDO1, DCLK1 and FOXC1 in Triple-negative breast cancer: morphological and clinical correlations]. 分子标记物IDO1、DCLK1和FOXC1在三阴性乳腺癌中的预后价值:形态学和临床相关性。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258703188
N V Krakhmal, M I Taranenko, S S Naumov, S V Vtorushin

Breast cancer (BC) with triple-negative molecular profile is characterized by special and rather serious problems in terms of clinical management of patients compared to other types. On the one hand this is due to the fact that tumors with such a status often do not respond to routine targeted therapy and only a minimal number of drugs are currently available for their treatment. On the other hand, cases of triple-negative BC (TNBC) are often diagnosed against the background of an extensive metastatic process, in which confirmation of the metastases histogenesis to breast tissue is a difficult task due to the low sensitivity of such carcinomas to specific organ markers. It is known that about 40-50% of all TNBC cases are characterized by the achievement of complete pathomorphological regression of the primary tumor as a result of neoadjuvant chemotherapy courses, which determines a favorable prognosis of the disease. In other cases (also up to 50%), TNBC do not respond to chemotherapy and exhibit persistent drug resistance, such tumors are more aggressive, have the highest relapse rate and a high risk of metastasis. For this group of patients, the issue of finding predictive markers and new therapeutic methods remains unresolved. The presented literature review reflects the data of the analysis of publicly available results of scientific studies devoted to potentially promising molecular markers, including IDO1, DCLK1 and FOXC1, their significance in BC, including TNBC is described. Based on the analysis of literary data, it can be argued that IDO1, DCLK1 and FOXC1 are promising objects for further research in the context of TNBC. Each marker has unique characteristics that make them important both for disease prognosis and for the development of new therapeutic approaches.

与其他类型的乳腺癌相比,具有三阴性分子谱的乳腺癌在患者的临床管理方面具有特殊且相当严重的问题。一方面,这是因为具有这种状态的肿瘤通常对常规靶向治疗没有反应,而且目前只有很少的药物可用于治疗。另一方面,三阴性BC (TNBC)的病例通常是在广泛转移过程的背景下诊断出来的,由于这种肿瘤对特定器官标志物的敏感性较低,因此确认转移组织发生到乳腺组织是一项困难的任务。据了解,在所有TNBC病例中,约有40-50%的患者通过新辅助化疗使原发肿瘤的病理形态完全消退,这决定了该疾病的良好预后。在其他情况下(也高达50%),TNBC对化疗没有反应,并表现出持续的耐药性,这类肿瘤更具侵袭性,复发率最高,转移风险高。对于这组患者,寻找预测标记物和新的治疗方法的问题仍然没有解决。本文的文献综述反映了对潜在有前途的分子标记(包括IDO1、DCLK1和FOXC1)的公开科学研究结果的分析数据,并描述了它们在BC(包括TNBC)中的意义。根据文献资料分析,IDO1、DCLK1和FOXC1是TNBC背景下有希望进一步研究的对象。每个标记物都有其独特的特征,这使得它们对疾病预后和新治疗方法的发展都很重要。
{"title":"[Prognostic value of molecular markers IDO1, DCLK1 and FOXC1 in Triple-negative breast cancer: morphological and clinical correlations].","authors":"N V Krakhmal, M I Taranenko, S S Naumov, S V Vtorushin","doi":"10.17116/patol20258703188","DOIUrl":"https://doi.org/10.17116/patol20258703188","url":null,"abstract":"<p><p>Breast cancer (BC) with triple-negative molecular profile is characterized by special and rather serious problems in terms of clinical management of patients compared to other types. On the one hand this is due to the fact that tumors with such a status often do not respond to routine targeted therapy and only a minimal number of drugs are currently available for their treatment. On the other hand, cases of triple-negative BC (TNBC) are often diagnosed against the background of an extensive metastatic process, in which confirmation of the metastases histogenesis to breast tissue is a difficult task due to the low sensitivity of such carcinomas to specific organ markers. It is known that about 40-50% of all TNBC cases are characterized by the achievement of complete pathomorphological regression of the primary tumor as a result of neoadjuvant chemotherapy courses, which determines a favorable prognosis of the disease. In other cases (also up to 50%), TNBC do not respond to chemotherapy and exhibit persistent drug resistance, such tumors are more aggressive, have the highest relapse rate and a high risk of metastasis. For this group of patients, the issue of finding predictive markers and new therapeutic methods remains unresolved. The presented literature review reflects the data of the analysis of publicly available results of scientific studies devoted to potentially promising molecular markers, including IDO1, DCLK1 and FOXC1, their significance in BC, including TNBC is described. Based on the analysis of literary data, it can be argued that IDO1, DCLK1 and FOXC1 are promising objects for further research in the context of TNBC. Each marker has unique characteristics that make them important both for disease prognosis and for the development of new therapeutic approaches.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 3","pages":"88-96"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparative analysis of morphometric and histological characteristics of HPV-associated and HPV-independent vulvar squamous cell carcinoma]. [hpv相关和不相关外阴鳞状细胞癌形态学和组织学特征的比较分析]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258703126
M I Pakharukova, B G Yushkov

Squamous cell carcinomas of the vulva are divided into human papillomavirus (HPV)-associated and HPV-independent. There is a need to determine the most effective methods for determining the HPV status of a tumor. Differences in the morphological structure of carcinomas have been shown, but the histological type of tumor does not fully reflect the differences in cell size for understanding the mechanisms of carcinogenesis.

Objective: To compare the morphometric and histological characteristics of HPV-associated and HPV-independent vulvar carcinomas and to calculate the specificity of histological, immunohistochemical methods and detection of viral DNA in establishing the HPV status of the tumor.

Material and methods: The study retrospectively included 74 patients. HPV typing was performed by real-time PCR, expression of p16 and p53 was determined by immunohistochemical method. The total area of tumor cells, the area of the cytoplasm and the nucleus were measured, and the nuclear-cytoplasmic ratio was calculated.

Results: HPV-independent carcinomas are predominantly keratinizing (94.3%). HPV-associated carcinomas are of basaloid histotype in 57.1% of cases and keratinizing in 42.9%. (42.9%). HPV-associated tumor cells are smaller (Me 223.89) compared to HPV-independent carcinoma cells (Me 525.95). The nuclear-cytoplasmic ratio was higher in HPV-associated carcinomas (Me 0.46 vs 0.18). The specificity of determining HPV status using histological characteristics of the tumor was 80.65%, immunohistochemical method - 96.36%, detection of viral DNA in the tumor - 75.47%.

Conclusion: A smaller cell area and a nuclear-cytoplasmic ratio shift toward the nucleus characterize HPV-associated carcinomas. With HPV-independent carcinogenesis, tumor cells more often retain the ability to differentiate and mature the epithelium. Immunohistochemical determination of p16 and p53 expression is a more accurate method for determining the HPV status of vulvar carcinoma.

外阴鳞状细胞癌分为人乳头瘤病毒(HPV)相关和人乳头瘤病毒无关。有必要确定最有效的方法来确定肿瘤的HPV状态。肿瘤在形态结构上的差异已被证实,但肿瘤的组织学类型并不能完全反映细胞大小的差异,对了解癌变机制有重要意义。目的:比较HPV相关外阴癌和HPV非相关外阴癌的形态学和组织学特征,计算组织学、免疫组织化学方法和病毒DNA检测在确定肿瘤HPV状态中的特异性。材料和方法:回顾性研究74例患者。实时荧光定量PCR法检测HPV分型,免疫组化法检测p16、p53的表达。测定肿瘤细胞的总面积、胞质面积和细胞核面积,计算核质比。结果:hpv非依赖性癌以角化为主(94.3%)。hpv相关癌为基底样组织型占57.1%,角化占42.9%。(42.9%)。hpv相关的肿瘤细胞(me223.89)比不依赖hpv的癌细胞(me525.95)要小。hpv相关癌的核质比更高(me0.46 vs 0.18)。利用肿瘤组织学特征确定HPV状态的特异性为80.65%,免疫组织化学法为96.36%,肿瘤病毒DNA检测为75.47%。结论:hpv相关癌的特征是细胞面积较小,核质比向细胞核移动。在不依赖hpv的癌变中,肿瘤细胞通常保留分化和上皮成熟的能力。免疫组化检测p16和p53的表达是判断外阴癌HPV状态较为准确的方法。
{"title":"[Comparative analysis of morphometric and histological characteristics of HPV-associated and HPV-independent vulvar squamous cell carcinoma].","authors":"M I Pakharukova, B G Yushkov","doi":"10.17116/patol20258703126","DOIUrl":"https://doi.org/10.17116/patol20258703126","url":null,"abstract":"<p><p>Squamous cell carcinomas of the vulva are divided into human papillomavirus (HPV)-associated and HPV-independent. There is a need to determine the most effective methods for determining the HPV status of a tumor. Differences in the morphological structure of carcinomas have been shown, but the histological type of tumor does not fully reflect the differences in cell size for understanding the mechanisms of carcinogenesis.</p><p><strong>Objective: </strong>To compare the morphometric and histological characteristics of HPV-associated and HPV-independent vulvar carcinomas and to calculate the specificity of histological, immunohistochemical methods and detection of viral DNA in establishing the HPV status of the tumor.</p><p><strong>Material and methods: </strong>The study retrospectively included 74 patients. HPV typing was performed by real-time PCR, expression of p16 and p53 was determined by immunohistochemical method. The total area of tumor cells, the area of the cytoplasm and the nucleus were measured, and the nuclear-cytoplasmic ratio was calculated.</p><p><strong>Results: </strong>HPV-independent carcinomas are predominantly keratinizing (94.3%). HPV-associated carcinomas are of basaloid histotype in 57.1% of cases and keratinizing in 42.9%. (42.9%). HPV-associated tumor cells are smaller (Me 223.89) compared to HPV-independent carcinoma cells (Me 525.95). The nuclear-cytoplasmic ratio was higher in HPV-associated carcinomas (Me 0.46 vs 0.18). The specificity of determining HPV status using histological characteristics of the tumor was 80.65%, immunohistochemical method - 96.36%, detection of viral DNA in the tumor - 75.47%.</p><p><strong>Conclusion: </strong>A smaller cell area and a nuclear-cytoplasmic ratio shift toward the nucleus characterize HPV-associated carcinomas. With HPV-independent carcinogenesis, tumor cells more often retain the ability to differentiate and mature the epithelium. Immunohistochemical determination of p16 and p53 expression is a more accurate method for determining the HPV status of vulvar carcinoma.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 3","pages":"26-32"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The phenomenon of tumor budding in gastric cancer]. [胃癌的肿瘤萌芽现象]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258702179
T M Polushkina, E E Porubaeva, N V Danilova

Gastric cancer remains the fifth most common malignant neoplasm in the world and ranks fifth among the causes associated with cancer. The TNM system remains the gold standard for predictive stratification of patients with gastric cancer, but the search for new sensitive, specific and reproducible biomarkers to develop a personalized approach to the management of patients with gastric cancer does not lose its relevance. The phenomenon of tumor budding is a well-established independent prognostic factor in colorectal cancer. In 2017, the first guideline on the method of calculating tumor budding for colorectal cancer was published. Despite the promising potential of using tumor budding in gastric cancer this parameter is still not evaluated in everyday practice. This lection provides data on various methods of counting tumor budding in gastric carcinomas, describes the molecular mechanisms of interaction between tumor cells and the immune microenvironment, and summarizes the available data on the relationship of clinical and morphological characteristics of gastric cancer with the degree of tumor budding. The relationship between the degree of tumor budding and the prognostic characteristics of gastric cancer and the prospects for its use is also described.

胃癌仍然是世界上第五大最常见的恶性肿瘤,在与癌症相关的原因中排名第五。TNM系统仍然是胃癌患者预测分层的金标准,但寻找新的敏感、特异性和可重复的生物标志物来开发个性化的胃癌患者管理方法并没有失去其相关性。肿瘤萌芽现象是结直肠癌的一个公认的独立预后因素。2017年,我国首份《结直肠癌肿瘤萌芽计算方法指南》发布。尽管在胃癌中使用肿瘤萌芽有很大的潜力,但在日常实践中仍未对该参数进行评估。本选集提供了胃癌中各种肿瘤出芽计数方法的资料,描述了肿瘤细胞与免疫微环境相互作用的分子机制,总结了胃癌临床和形态学特征与肿瘤出芽程度关系的现有资料。并对肿瘤出芽程度与胃癌预后特征的关系及其应用前景进行了展望。
{"title":"[The phenomenon of tumor budding in gastric cancer].","authors":"T M Polushkina, E E Porubaeva, N V Danilova","doi":"10.17116/patol20258702179","DOIUrl":"https://doi.org/10.17116/patol20258702179","url":null,"abstract":"<p><p>Gastric cancer remains the fifth most common malignant neoplasm in the world and ranks fifth among the causes associated with cancer. The TNM system remains the gold standard for predictive stratification of patients with gastric cancer, but the search for new sensitive, specific and reproducible biomarkers to develop a personalized approach to the management of patients with gastric cancer does not lose its relevance. The phenomenon of tumor budding is a well-established independent prognostic factor in colorectal cancer. In 2017, the first guideline on the method of calculating tumor budding for colorectal cancer was published. Despite the promising potential of using tumor budding in gastric cancer this parameter is still not evaluated in everyday practice. This lection provides data on various methods of counting tumor budding in gastric carcinomas, describes the molecular mechanisms of interaction between tumor cells and the immune microenvironment, and summarizes the available data on the relationship of clinical and morphological characteristics of gastric cancer with the degree of tumor budding. The relationship between the degree of tumor budding and the prognostic characteristics of gastric cancer and the prospects for its use is also described.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 2","pages":"79-87"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Characteristics of the immune microenvironment of endometrial cancer depending on the MMR status of the tumor]. [子宫内膜癌免疫微环境与肿瘤MMR状态的关系特征]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258705111
A Yu Kalinchuk, A A Maltseva, E A Tsarenkova, D M Loos, S V Vtorushin, L A Kolomiets, L A Tashireva

Objective: To study the microenvironment features of MMR-proficient (pMMR) and MMR-deficient (dMMR) endometrial cancer.

Material and methods: The study included 34 patients with pMMR endometrial cancer and 10 patients with dMMR endometrial cancer. Using the method of multiplex TSA-associated (tyramide signal amplification) immunofluorescence, phenotyping of the tumor microenvironment was performed with an assessment of stromal and intratumor cell localization and PD-1 expression.

Results: In pMMR endometrial tumors, the predominant cell population was CD163+ macrophages, and in tumors with dMMR, CD163+ macrophages were found equally with CD8+ T lymphocytes and CD20+ B lymphocytes. In dMMR tumors, the number of CD8+ T lymphocytes and CD20+ B lymphocytes (as well as CD20+ B lymphocytes expressing PD-1) is higher compared to pMMR tumors, while the number of FoxP3+ T lymphocytes was significantly lower. The number of CD163+ macrophages did not differ depending on the MMR status, while the number of CD163+ macrophages was higher in the stroma compared to the number of these cells located intraepithelially. In patients with dMMR tumors, the number of CD8+ T lymphocytes was higher in the stroma, and did not differ in pMMR tumors.

Conclusion: In this study, it was found that dMMR endometrial tumors are characterized by an increase in the proportion of CD8+ T lymphocytes and CD20+ B lymphocytes, which may be associated with a better response to immunotherapy. The differences in spatial distribution of CD8+ T lymphocytes and CD163+ macrophages confirmed the importance of immune cell localization for prognosis and treatment efficacy. These results highlight the need for further study of the endometrial cancer microenvironment in order to personalize therapy.

目的:探讨mmr熟练型(pMMR)和mmr缺陷型(dMMR)子宫内膜癌的微环境特征。材料与方法:本研究纳入34例pMMR子宫内膜癌患者和10例dMMR子宫内膜癌患者。采用多重tsa相关(酪酰胺信号扩增)免疫荧光方法,通过评估间质和肿瘤内细胞定位以及PD-1表达对肿瘤微环境进行表型分析。结果:pMMR子宫内膜肿瘤中以CD163+巨噬细胞为主,dMMR肿瘤中CD163+巨噬细胞与CD8+ T淋巴细胞和CD20+ B淋巴细胞数量相等。在dMMR肿瘤中,CD8+ T淋巴细胞和CD20+ B淋巴细胞(以及表达PD-1的CD20+ B淋巴细胞)的数量高于pMMR肿瘤,而FoxP3+ T淋巴细胞的数量明显低于pMMR肿瘤。CD163+巨噬细胞的数量不因MMR状态而异,而间质中CD163+巨噬细胞的数量高于位于上皮内的细胞数量。dMMR肿瘤患者间质中CD8+ T淋巴细胞数量较高,pMMR肿瘤中CD8+ T淋巴细胞数量无差异。结论:本研究发现dMMR子宫内膜肿瘤具有CD8+ T淋巴细胞和CD20+ B淋巴细胞比例升高的特点,这可能与免疫治疗应答较好有关。CD8+ T淋巴细胞和CD163+巨噬细胞的空间分布差异证实了免疫细胞定位对预后和治疗效果的重要性。这些结果强调了进一步研究子宫内膜癌微环境以个性化治疗的必要性。
{"title":"[Characteristics of the immune microenvironment of endometrial cancer depending on the MMR status of the tumor].","authors":"A Yu Kalinchuk, A A Maltseva, E A Tsarenkova, D M Loos, S V Vtorushin, L A Kolomiets, L A Tashireva","doi":"10.17116/patol20258705111","DOIUrl":"https://doi.org/10.17116/patol20258705111","url":null,"abstract":"<p><strong>Objective: </strong>To study the microenvironment features of MMR-proficient (pMMR) and MMR-deficient (dMMR) endometrial cancer.</p><p><strong>Material and methods: </strong>The study included 34 patients with pMMR endometrial cancer and 10 patients with dMMR endometrial cancer. Using the method of multiplex TSA-associated (tyramide signal amplification) immunofluorescence, phenotyping of the tumor microenvironment was performed with an assessment of stromal and intratumor cell localization and PD-1 expression.</p><p><strong>Results: </strong>In pMMR endometrial tumors, the predominant cell population was CD163+ macrophages, and in tumors with dMMR, CD163+ macrophages were found equally with CD8+ T lymphocytes and CD20+ B lymphocytes. In dMMR tumors, the number of CD8+ T lymphocytes and CD20+ B lymphocytes (as well as CD20+ B lymphocytes expressing PD-1) is higher compared to pMMR tumors, while the number of FoxP3+ T lymphocytes was significantly lower. The number of CD163+ macrophages did not differ depending on the MMR status, while the number of CD163+ macrophages was higher in the stroma compared to the number of these cells located intraepithelially. In patients with dMMR tumors, the number of CD8+ T lymphocytes was higher in the stroma, and did not differ in pMMR tumors.</p><p><strong>Conclusion: </strong>In this study, it was found that dMMR endometrial tumors are characterized by an increase in the proportion of CD8+ T lymphocytes and CD20+ B lymphocytes, which may be associated with a better response to immunotherapy. The differences in spatial distribution of CD8+ T lymphocytes and CD163+ macrophages confirmed the importance of immune cell localization for prognosis and treatment efficacy. These results highlight the need for further study of the endometrial cancer microenvironment in order to personalize therapy.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 5","pages":"11-19"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145375941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Morphogenesis and molecular regulation of polyposis rhinosinusitis]. 息肉病性鼻窦炎的形态发生与分子调控。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258701168
N Yu Matveeva, D G Pavlush, S G Kalinichenko

Polyposis rhinosinusitis (CRSwNP) is a heterogeneous proliferative disease characterized by inflammatory hyperplasia of the nasal mucosa with dysregulation of apoptosis and cell differentiation. The review summarizes data on the molecular cellular mechanisms of CRSwNP and presents the concept of intercellular signaling during polyposis growth. Various factors that form a specific endotype are involved in the development of a polyp. Features of morphogenesis make it possible to distinguish edematous, eosinophilic and fibrous NP. In all cases, markers of neurogenic inflammation, impaired expression of proinflammatory cytokines, NO synthase, BMP-2 and other morphogenetic molecules arerecorded. The growing polyp and the inflammatory reaction damage the epithelium of the mucous membrane and bone wall of the nasal cavity. Interleukin-1β and BMP-2 are an integrative link in the pathogenesis of these events.

鼻息肉病(CRSwNP)是一种异质性增殖性疾病,其特征是鼻黏膜炎症性增生,细胞凋亡和细胞分化失调。本文综述了CRSwNP的分子细胞机制,并介绍了息肉病生长过程中细胞间信号传导的概念。形成特定内型的各种因素参与了息肉的发展。形态发生的特征使得区分水肿性、嗜酸性和纤维性NP成为可能。在所有病例中,记录了神经源性炎症标志物、促炎细胞因子、NO合成酶、BMP-2和其他形态发生分子的表达受损。生长的息肉和炎症反应损伤鼻腔粘膜上皮和骨壁。白细胞介素-1β和BMP-2在这些事件的发病机制中是一个综合的环节。
{"title":"[Morphogenesis and molecular regulation of polyposis rhinosinusitis].","authors":"N Yu Matveeva, D G Pavlush, S G Kalinichenko","doi":"10.17116/patol20258701168","DOIUrl":"10.17116/patol20258701168","url":null,"abstract":"<p><p>Polyposis rhinosinusitis (CRSwNP) is a heterogeneous proliferative disease characterized by inflammatory hyperplasia of the nasal mucosa with dysregulation of apoptosis and cell differentiation. The review summarizes data on the molecular cellular mechanisms of CRSwNP and presents the concept of intercellular signaling during polyposis growth. Various factors that form a specific endotype are involved in the development of a polyp. Features of morphogenesis make it possible to distinguish edematous, eosinophilic and fibrous NP. In all cases, markers of neurogenic inflammation, impaired expression of proinflammatory cytokines, NO synthase, BMP-2 and other morphogenetic molecules arerecorded. The growing polyp and the inflammatory reaction damage the epithelium of the mucous membrane and bone wall of the nasal cavity. Interleukin-1β and BMP-2 are an integrative link in the pathogenesis of these events.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 1","pages":"68-76"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arkhiv patologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1